Long-term effects of biologic therapies on peripheral blood eosinophils in patients with psoriasis: a 3-year single-center study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Dermatological Treatment"
DOI: 10.1080/09546634.2019.1605139
Abstract: Abstract Background: Biologic therapies (BTs), etanercept, infliximab, adalimumab, and ustekinumab, are generally well-tolerated and safe agents in psoriasis management. Objectives: To determine the overall effect of BTs on peripheral blood eosinophil count (PBEc) and percentage… read more here.
Keywords: biologic therapies; patients psoriasis; peripheral blood; blood ... See more keywords
Emerging biologic therapies for hypercholesterolaemia
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2017.1341485
Abstract: ABSTRACT Introduction: LDL-cholesterol (LDL-C) is one of the most well-established risk factors for CV disease. Indeed, therapies that decrease LDL-C are proven to effectively reduce the risk of atherosclerotic CV disease. Monoclonal antibodies (mAbs) that… read more here.
Keywords: reduction; biologic therapies; risk; pcsk9 ... See more keywords
Immunogenicity of biologic therapies: causes and consequences
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2018.1468753
Abstract: ABSTRACT Introduction: Antibodies or fusion proteins termed biologics allow the targeted therapy of diseases. Many of these agents have proven superior efficacy and safety to conventional therapies, and subsequently revolutionized the management of numerous chronic… read more here.
Keywords: therapies causes; biologic therapies; immunogenicity biologic; immunogenicity ... See more keywords
Biologic Therapies in HIV/AIDS Patients with Inflammatory Diseases: A Systematic Review of the Literature.
Sign Up to like & getrecommendations! Published in 2023 at "AIDS patient care and STDs"
DOI: 10.1089/apc.2022.0197
Abstract: Biologic therapies have been increasingly developed and used for the treatment of severe inflammatory diseases. However, the safety and efficacy profile of biologic drugs in patients with HIV is not well established as this patient… read more here.
Keywords: safety; inflammatory diseases; systematic review; review literature ... See more keywords
Comparative Efficacy of Biologic Therapies for Inducing Response and Remission in Fistulizing Crohn's Disease: Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Sign Up to like & getrecommendations! Published in 2022 at "Inflammatory bowel diseases"
DOI: 10.1093/ibd/izac103
Abstract: BACKGROUND The medical treatment of fistulizing Crohn's disease (CD) remains a challenge to clinicians. Over the last 20 years, biologic therapies have been the mainstay of medical treatment of fistulizing CD. The purpose of this… read more here.
Keywords: efficacy biologic; response remission; inducing response; remission ... See more keywords
Defining trajectories of response in patients with psoriasis treated with biologic therapies
Sign Up to like & getrecommendations! Published in 2021 at "British Journal of Dermatology"
DOI: 10.1111/bjd.20140
Abstract: The effectiveness and cost‐effectiveness of biologic therapies for psoriasis are significantly compromised by variable treatment responses. Thus, more precise management of psoriasis is needed. read more here.
Keywords: biologic therapies; patients psoriasis; response patients; psoriasis ... See more keywords
Current use of biologic therapies for musculoskeletal disease: A survey of board‐certified equine specialists
Sign Up to like & getrecommendations! Published in 2022 at "Veterinary Surgery"
DOI: 10.1111/vsu.13805
Abstract: Abstract Objective To evaluate the use of mesenchymal stem cells (MSCs), autologous conditioned serum (ACS), platelet‐rich plasma (PRP), and autologous protein solution (APS) for the treatment of equine musculoskeletal disease by diplomates of the American… read more here.
Keywords: disease; prp; survey; musculoskeletal disease ... See more keywords
Treatment Pathways Leading to Biologic Therapies for Ulcerative Colitis and Crohn's Disease in the United States
Sign Up to like & getrecommendations! Published in 2020 at "Clinical and Translational Gastroenterology"
DOI: 10.14309/ctg.0000000000000128
Abstract: OBJECTIVES: Biologic therapies have been available for inflammatory bowel disease for >20 years, but patient outcomes have not changed appreciably over this time period. To better understand medication utilization for this disease, we evaluated a… read more here.
Keywords: treatment pathways; biologic therapies; treatment; colitis crohn ... See more keywords
COVID-19 and adherence to biologic therapies for psoriasis: An analysis of nationwide pharmacy claims data.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2022.28.11.1213
Abstract: BACKGROUND: Early after the onset of the COVID-19 pandemic, concerns were raised that the use of psoriasis treatments, particularly biologic therapies because of their immunosuppressant effects, could be associated with a poor prognosis in the… read more here.
Keywords: therapies psoriasis; pharmacy claims; incidence; pharmacy ... See more keywords
Biologic Therapies in Pediatric Asthma
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Personalized Medicine"
DOI: 10.3390/jpm12060999
Abstract: Undeniably, childhood asthma is a multifactorial and heterogeneous chronic condition widespread in children. Its management, especially of the severe form refractory to standard therapy remains challenging. Over the past decades, the development of biologic agents… read more here.
Keywords: pediatric asthma; biologic therapies; medicine; therapies pediatric ... See more keywords
Biologic Therapies for Asthma and Allergic Disease: Past, Present, and Future
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16020270
Abstract: The discovery of the mechanism underlying allergic disease, mouse models of asthma, and bronchoscopy studies provided initial insights into the role of Th2-type cytokines, including interlukin (IL)-4, IL-5 and IL-13, which became the target of… read more here.
Keywords: therapies asthma; asthma allergic; disease; allergic disease ... See more keywords